ID: ALA550919

Max Phase: Preclinical

Molecular Formula: C42H52O11

Molecular Weight: 732.87

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc([C@@H](O)[C@@H](C)Oc2ccc([C@H]3O[C@H](c4ccc(O[C@H](C)[C@H](O)c5ccc(OC)c(OC)c5)c(OC)c4)[C@H](C)[C@H]3C)cc2OC)cc1OC

Standard InChI:  InChI=1S/C42H52O11/c1-23-24(2)42(30-14-18-34(38(22-30)50-10)52-26(4)40(44)28-12-16-32(46-6)36(20-28)48-8)53-41(23)29-13-17-33(37(21-29)49-9)51-25(3)39(43)27-11-15-31(45-5)35(19-27)47-7/h11-26,39-44H,1-10H3/t23-,24-,25-,26-,39+,40+,41+,42+/m1/s1

Standard InChI Key:  ZGXXNVOBEIRACL-VOGCUZRYSA-N

Associated Targets(non-human)

Lewis lung carcinoma cell line 1243 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 732.87Molecular Weight (Monoisotopic): 732.3510AlogP: 7.82#Rotatable Bonds: 16
Polar Surface Area: 123.53Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.13CX Basic pKa: CX LogP: 6.59CX LogD: 6.59
Aromatic Rings: 4Heavy Atoms: 53QED Weighted: 0.12Np Likeness Score: 0.60

References

1. Kwak SH, Stephenson TN, Lee HE, Ge Y, Lee H, Min SM, Kim JH, Kwon DY, Lee YM, Hong J..  (2020)  Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition.,  63  (13): [PMID:32579356] [10.1021/acs.jmedchem.0c00151]

Source